Purpose Unlimited’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$708K Buy
4,964
+4,445
+856% +$674K 0.03% 147
2026
Q2
$81.6K Sell
519
-14
-3% -$2.1K ﹤0.01% 304
2026
Q1
$81.4K Sell
533
-61
-10% -$9.35K ﹤0.01% 299
2025
Q4
$81.9K Buy
+594
New +$77.8K ﹤0.01% 223

Other funds holding NVS

Purpose Unlimited's NVS Position: Q3 2026 in Review

Purpose Unlimited increased its Novartis (NVS) stake by 856% in Q3 2026, buying an estimated $674K and bringing the position to 4,964 shares worth $708K. The position accounts for 0.03% of the portfolio, ranked #147.

Purpose Unlimited first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Purpose Unlimited held 4,964 shares of Novartis worth $708K as of Q3 2026.
  • Purpose Unlimited bought 4,445 Novartis shares in Q3 2026, an estimated $674K.
  • Novartis made up 0.03% of Purpose Unlimited's portfolio in Q3 2026, its #147 holding.
  • Purpose Unlimited first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Purpose Unlimited's 13F filing for Q3 2026, filed 12 Nov 2026.